A meta-analysis of the association between Chlamydia pneumoniae infection and lung cancer risk

Indian Journal of Cancer

Volumn 52, Issue 6, 2015, Pages e112-e115

  Hua Feng, X ^a   Yue Ming, W ^a   Hong, L ^a   Junyi, D ^a  

^a LISHUI PEOPLE S HOSPITAL   (China)

Author keywords

Chlamydia pneumoniae infection; lung cancer; meta analysis; risk factors

Indexed keywords

ARTICLE; CANCER RISK; CHLAMYDIAL PNEUMONIA; DISEASE ASSOCIATION; HUMAN; LUNG CANCER; CHINA; CHLAMYDIA PNEUMONIAE; CHLAMYDIASIS; COMPLICATION; LUNG NEOPLASMS; META ANALYSIS; MICROBIOLOGY; PATHOGENICITY; PROGNOSIS; RISK FACTOR;

CHINA; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; HUMANS; LUNG NEOPLASMS; PROGNOSIS; RISK FACTORS;

EID: 84954162565     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.172506     Document Type: Article

References (19)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
3. Islami F, Torre LA, Jemal A. Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res 2015;4:327-38.
4. Ou SH. Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy? J Clin Pathol 2013;66:839-46.
5. Fei H, Lin C. Association between Chlamydia pneumonia infection and lung cancer risk. Chin J Public Health 2014;12:70-3.
6. Anttila T, Koskela P, Leinonen M, Laukkanen P, Hakulinen T, Lehtinen M, et al. Chlamydia pneumoniae infection and the risk of female early-onset lung cancer. Int J Cancer 2003;107:681-2.
7. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
8. Chaturvedi AK, Gaydos CA, Agreda P, Holden JP, Chatterjee N, Goedert JJ, et al. Chlamydia pneumoniae infection and risk for lung cancer. Cancer Epidemiol Biomarkers Prev 2010;19:1498-505.
9. Smith JS, Kumlin U, Nyberg F, Fortes C, Zaridze D, Ahrens W, et al. Lack of association between serum antibodies of Chlamydia pneumoniae infection and the risk of lung cancer. Int J Cancer 2008;123:2469-71.
10. Chen YB, Tao YD, Ling CH, Lin W. The association between Chlamydia pneumoniae infection and lung cancer risk. Chin J Public Health 2014;17:69-72.
11. Koh WP, Chow VT, Phoon MC, Ramachandran N, Seow A. Lack of association between chronic Chlamydophila pneumoniae infection and lung cancer among nonsmoking Chinese women in Singapore. Int J Cancer 2005;114:502-4.
12. Littman AJ, White E, Jackson LA, Thornquist MD, Gaydos CA, Goodman GE, et al. Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1624-30.
13. Chen YQ, Li LM, Wang FC. The research of Chlamydia pneumoniae infection in patients with lung cancer. Chin J Zoonoses 2001;17:46-9.
14. Koyi H, Brandén E, Gnarpe J, Gnarpe H, Steen B. An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study. APMIS 2001;109:572-80.
15. Xiong ZY, Chen WS, Li TQ, et al. Comparison of Mycoplasma pneumoniae infection in patients with lung cancer and chronic obstructive pulmonary disease. J West China Univ Med Sci 2000;31:124-5.
16. Jackson LA, Wang SP, Nazar-Stewart V, Grayston JT, Vaughan TL. Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2000;9:1263-6.
17. Laurila AL, Anttila T, Läärä E, Bloigu A, Virtamo J, Albanes D, et al. Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer 1997;74:31-4.
18. Schmidt-Hansen M, Page R, Hasler E. The effect of preoperative smoking cessation or preoperative pulmonary rehabilitation on outcomes after lung cancer surgery: A systematic review. Clin Lung Cancer 2013;14:96-102.
19. Anwar S. Evidence based medicine, systematic reviews and meta-analysis of literature: A powerful tool for the practising doctor. J Coll Physicians Surg Pak 2007;17:123-4.